Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AB INBEV ABI Feb 26, 2021 47.46 -4.89   
 Ackermans & van Haaren NV ACKB Feb 26, 2021 133.60 +2.61   
 Aedifica SA AED Feb 26, 2021 103.00 -1.90   
 Ageas AGS Feb 26, 2021 46.46 -0.81   
 APERAM APAM Feb 26, 2021 34.70 -1.98   
 Argen X SE ARGX Feb 26, 2021 277.60 -0.43   
 Barco NV BAR Feb 26, 2021 20.34 -3.60   
 Bel20 BEL20 Feb 26, 2021 3 761.99 -2.29   
 Cofinimmo COFB Feb 26, 2021 128.40 -1.23   
 Colruyt SA COLR Feb 26, 2021 49.64 -1.27   
 GALAPAGOS GLPG Feb 26, 2021 68.26 -3.31   
 Groupe Bruxelles Lambert SA GBLB Feb 26, 2021 82.16 -0.89   
 ING GROEP N.V. INGA Feb 26, 2021 9.04 -2.05   
 KBC Groep NV KBC Feb 26, 2021 59.62 -4.06   
 Proximus SADP PROX Feb 26, 2021 16.20 -11.38   
 Sofina SA SOF Feb 26, 2021 274.50 -1.79   
 Solvay SA SOLB Feb 26, 2021 101.10 +0.05   
 Telenet Group Holding NV TNET Feb 26, 2021 33.04 -1.78   
 UCB SA UCB Feb 26, 2021 82.44 -4.14   
 Umicore SA UMI Feb 26, 2021 48.66 -0.61   
 Warehousing & Distribution De Pauw WDP Feb 26, 2021 28.34 -1.60   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK